New Providence Acquisition Corp. III Class A (NPAC)

NASDAQ:NPAC

NPAC

New Providence Acquisition Corp. III Class A

RESEARCH TOOLSreports

Want to see NPAC full AI Analyst Report?

Compare New Providence Acquisition Corp. III Class A (NPAC) vs. Competitors

0 Followers

Comparison Results

NPAC

New Providence Acquisition Corp. III Class A

$10.30

$396.57M

51.31

-0.68%

―

Bayview Acquisition Corp Class A

$11.92

$32.72M

28.28

9.08%

―

Roma Green Finance Limited

$5.36

$365.13M

-14.60

345.82%

―

FibroBiologics, Inc.

$1.53

$5.13M

-0.25

-92.84%

1 Buy

2 Hold

0 Sell

Moderate Buy

Alto Neuroscience, Inc.

$27.72

$796.72M

-8.12

917.96%

10 Buy

1 Hold

0 Sell

Strong Buy

Telomir Pharmaceuticals, Inc.

$1.35

$48.13M

-4.04

-44.22%

―

xxxxxxxxxxxxx

NPAC vs TELO

xxxxxxxxxxxxx

Performance Comparison

NPAC

New Providence Acquisition Corp. III Class A

10.33

-0.02

-0.20%

BAYA

Bayview Acquisition Corp Class A

11.95

0.99

9.03%

ROMA

Roma Green Finance Limited

6.13

4.59

298.05%

FBLG

FibroBiologics, Inc.

1.46

-17.56

-92.33%

ANRO

Alto Neuroscience, Inc.

24.94

22.59

961.28%

TELO

Telomir Pharmaceuticals, Inc.

1.40

-1.17

-45.53%

Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts

Compare More Stocks >